Short-Term Morphofunctional Changes in Previously Treated Neovascular AMD Eyes Switched to Brolucizumab

The purpose of the study is to explore the morphofunctional fluctuations in eyes treated for neovascular AMD (nAMD) when treatment is switched from aflibercept or ranibizumab to brolucizumab. A total of 31 eyes of 31 patients with nAMD with type 1 macular neovascularization (MNV) were included. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Viggiano, Pasquale, Grassi, Maria Oliva, Boscia, Giacomo, Pignataro, Mariagrazia, Petruzzella, Giovanni, Borrelli, Enrico, Molfetta, Teresa, Alessio, Giovanni, Boscia, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570643/
https://www.ncbi.nlm.nih.gov/pubmed/36233385
http://dx.doi.org/10.3390/jcm11195517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570643/
https://www.ncbi.nlm.nih.gov/pubmed/36233385
http://dx.doi.org/10.3390/jcm11195517

Ejemplares similares